Zobrazeno 1 - 6
of 6
pro vyhledávání: '"T D Lutskaia"'
Autor:
A K Golenkov, I V Buravtsova, G A Dudina, T D Lutskaia, T A Mitina, E V Kataeva, A F Karamysheva, E S Kakpakova, Iu A Sablina, A A Stavrovskaia
Publikováno v:
Терапевтический архив, Vol 85, Iss 7, Pp 98-102 (2013)
AIM: To determine the significance of the angiogenic activity estimated from the gene expression of the vascular endothelial growth factors (VEGFs) VEGF-A, VEGF-C, and VEGF-D and their receptors VEGFR1, VEGFR1s, VEGFR2, and VEGFR3 in the mononuclear
Externí odkaz:
https://doaj.org/article/bdc6bdb6258e41b39621d4f6dc48fb05
Publikováno v:
Terapevticheskii arkhiv. 82(7)
To evaluate the effectiveness of bortezomib and bortezomib-containing treatment programs in the therapy of resistant and recurrent multiple myeloma (MM) within a large unicenter study in real clinical practice conditions.The study enrolled 101 patien
Publikováno v:
Vestnik otorinolaringologii. (1)
Autor:
A K, Golenkov, E V, Trifonova, E V, Kataeva, A V, Kil'diushevskiĭ, T D, Lutskaia, E A, Zariad'eva, I N, Nazarova, M N, Lukashina, T N, Zabotina, I N, Mikhaĭlova, A N, Inshakov, N P, Logacheva, A Iu, Baryshnikov
Publikováno v:
Terapevticheskii arkhiv. 72(8)
To determine sensitivity of tumor plasmocytes in vitro to cytostatic drugs (prednisolone, alkeran belustin, vincristine, rubomycin, doxorubicin, cytarabin, methotrexate, cysplatin, etoposide).The sensitivity was measured with DISC method in 12 patien
Autor:
A K, Golenkov, T D, Lutskaia, E N, Kliushnenkova, R S, Tishenina, L S, Valiulina, V E, Novikov, T A, Mitina
Publikováno v:
Terapevticheskii arkhiv. 68(7)
In 70 patients with stage III multiple myeloma (MM) the authors studied spontaneous and lipopolysaccharide-induced production of interleukin-1 (IL-1) and interleukin-6 (IL-6) by blood and bone marrow mononuclear cells, concentration of parathyroid ho
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 115(5)
Constitutive and lipopolysaccharide (LPS)--induced production of interleukin (IL)-1 and IL-6 have been investigated in peripheral blood (PB) and bone marrow (BM) of patients with multiple myeloma (MM) and PB of health donors. The level of these cytok